Protech Home Medical

  • Simplifying the Patient Experience!

  • 859-300-6455

    cole.stevens@myphm.com

  • 1019 Town Drive

    Wilder, KY 41076

PROTECH HOME MEDICAL ANNOUNCES DTC ELIGIBILITY FOR ITS COMMON SHARES DTC ELIGIBILITY EXPECTED TO INCREASE ACCESSIBILITY FOR U.S. INVESTORS


  •   8:00AM EST

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.

Cincinnati, Ohio – August 10, 2020 – Protech Home Medical Corp. (the “Company” or “Protech”) (TSXV: PTQ) (OTCQX: PTQQF), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is pleased to announce that its common shares (including those traded on the OTCQX) are now eligible for electronic clearing and settlement through the Depository Trust Company (“DTC”) in the United States.

DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered to be “DTC eligible”. DTC eligibility is expected to create a seamless process of trading and enhance liquidity of the Company's common shares in the United States over time.

The ability to have Protech’s shares electronically cleared and settled in the United States is far more convenient and reduces the costs incurred in trading shares. With Protech’s shares now traded electronically, existing investors benefit from greater liquidity over time and execution speeds, while new investors are far less restricted from participating in Protech’s stock.

“We are thrilled to conclude the process of obtaining DTC eligibility, as it represents a significant step forward for our current and future shareholders as it comes to building liquidity and is crucial in building a strong presence for our company within the U.S. capital markets sphere,” commented Greg Crawford, CEO and Chairman of Protech. “Simplifying the process of transacting our stock for investors and brokerage firms is extremely important and demonstrates our commitment to broadening our shareholder base.”